After considering the plain language of the patents, patent prosecution history and briefing and evidence presented by the parties, the Court issued a Markman ruling effectively shutting down Glycobiotics' interpretation. The Court's ruling allows Mannatech to continue to pursue its patent infringement claims against Glycobiotics International Inc., with a trial setting expected for late fall.
Mannatech is currently pursuing two patent infringement lawsuits against Glycobiotics International Inc., and K.Y.C. Inc., d/b/a Techmedica Health Inc. The lawsuits, which are still pending, are in response to several competitors using Mannatech's technology to create and offer copycat products.
